Print Version
What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine
Publication Date:
2012
Country of Origin:
United States
Format:
Information Sheet
Language:
English
Abstract
This information sheet discusses treatment for latent TB infection. It reminds patients to keep their weekly medical visits, explains directly observed therapy, provides a list of items to discuss with their doctor, a medication schedule, and advises them to call the doctor immediately if they experience any of the side effects on the list. The information sheet also includes space for the doctor's and clinic's name and telephone number.
Publisher:
Centers for Disease Control and Prevention,National Center for HIV Viral Hepatitis STD and TB Prevention
Audience(s):
General Public, Persons With LTBI
Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.